| __timestamp | Corcept Therapeutics Incorporated | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 1860000 |
| Thursday, January 1, 2015 | 36949000 | 2963000 |
| Friday, January 1, 2016 | 45240000 | 6961000 |
| Sunday, January 1, 2017 | 62416000 | 11779000 |
| Monday, January 1, 2018 | 81289000 | 13697000 |
| Tuesday, January 1, 2019 | 100359000 | 15749000 |
| Wednesday, January 1, 2020 | 105326000 | 18638000 |
| Friday, January 1, 2021 | 122356000 | 27196000 |
| Saturday, January 1, 2022 | 152848000 | 31739000 |
| Sunday, January 1, 2023 | 184259000 | 33491000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and profitability. Over the past decade, Corcept Therapeutics Incorporated and Protagonist Therapeutics, Inc. have demonstrated contrasting approaches to SG&A cost management. From 2014 to 2023, Corcept Therapeutics saw a steady increase in SG&A expenses, rising from approximately $35 million to $184 million, reflecting a growth of over 400%. In contrast, Protagonist Therapeutics maintained a more conservative trajectory, with expenses growing from $1.9 million to $33 million, marking a 17-fold increase. This divergence highlights Corcept's aggressive expansion strategy, while Protagonist's approach suggests a more cautious scaling. Understanding these trends offers valuable insights into how biotech firms balance operational costs with strategic growth, a critical factor for investors and stakeholders in the industry.
Novo Nordisk A/S vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Sanofi vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?